SCHEMBL17345964

SCHEMBL17345964

CSCCCNCCN(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
TDP1 Q9NUW8 1/20 0.45
PRMT3 O60678 1/20 0.39
CARM1 Q86X55 1/20 0.39
PRMT6 Q96LA8 1/20 0.39
PRMT1 Q99873 1/20 0.39
PRMT8 Q9NR22 1/20 0.39
PAOX Q6QHF9 1/20 0.37
KDM1A O60341 1/20 0.36
SIGMAR1 Q99720 1/20 0.33
KDM4E B2RXH2 4/20 0.33
ANPEP P15144 1/20 0.32
ALDH1A1 P00352 4/20 0.32
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MEN1 O00255 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
CA1 P00915 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17345968 0.91 TDP1 (0.56) CYP2C9CYP2C19TDP1PRMT3CARM1
SCHEMBL17345960 0.86 CYP2C9 (0.52) CYP2C9CYP2C19TDP1PRMT3CARM1
SCHEMBL8741137 0.80 CYP2C19 (0.70) CYP2C9CYP2C19TDP1PRMT3CARM1
SCHEMBL21704198 0.78 TSHR (0.38) CYP2C9CYP2C19TDP1KDM4EALDH1A1
SCHEMBL6141860 0.78 TDP1 (0.68) CYP2C9CYP2C19TDP1PRMT3CARM1
SCHEMBL344526 0.77 CYP2C9 (0.72) CYP2C9CYP2C19TDP1PRMT3CARM1
SCHEMBL11340107 0.75
SCHEMBL65120 0.74 CYP2C19 (0.68) CYP2C9CYP2C19TDP1PRMT3CARM1
SCHEMBL347138 0.74 CYP2C19 (0.68) CYP2C9CYP2C19TDP1PRMT3CARM1
Bromide SCHEMBL38656355 0.74 CYP2C9 (0.68) CYP2C9CYP2C19TDP1PRMT3CARM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS TRIAD NATIONAL SECURITY, LLC 2017-03-30 US disclosed
WO-2015191505-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS LOS ALAMOS NATIONAL SECURITY, LLC (US) 2015-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088571-A1 POLYDENTATE LIGANDS AND THEIR COMPLEXES FOR MOLECULAR CATALYSIS NANS, NCL, NCLN CYP2C9 3796/4885CYP2C19 4732/4885TDP1 2145/4885
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN CYP2C9 3796/4885CYP2C19 4732/4885TDP1 2145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.